Brief: Abeona Therapeutics Announces Submission Of Briefing Package For Pre-BLA Meeting
28/07/2023 13:46
July 28 (Reuters) - Abeona Therapeutics Inc ABEO.O :
* ABEONA THERAPEUTICS ANNOUNCES SUBMISSION OF BRIEFING
PACKAGE FOR
PRE-BIOLOGICS LICENSE APPLICATION (BLA) MEETING WITH FDA IN
AUGUST 2023
* ABEONA THERAPEUTICS INC - ANTICIPATE SUBMITTING EB-101 BLA
IN Q3
OF 2023
Source text for Eikon: ID:nGNX9PwchL
Further company coverage: ABEO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Abeona Therapeutics
See all newsBrief: Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Ultragenyx rises after FDA nod for rare disorder drug
U.S. STOCKS ON THE MOVE-Tapestry, Cisco, Sandisk
U.S. STOCKS ON THE MOVE-EnerSys, Netflix, Salesforce
U.S. STOCKS ON THE MOVE-Cerebras, Madison Square Garden Sports